ARCHIVES

Phase IIb Trial of Vintafolide-Docetaxel Combination Meets Primary Endpoint of Progression-Free Survival

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI Deputy Director Ihde To Leave Institute; Bynum To Retire; Lewis Thomas Dead At 80

December 10, 1993

RFAs available: Chemoprevention Clinical Trials

July 22, 1994

BRM Phase 1-2 Task Orders Awarded

November 21, 1980

A Year in Houston: DePinho Reflects on Plans, Conflicts, Controversies—and Lessons Learned

September 7, 2012

PET Better At Evaluating Response In Sarcoma

February 29, 2008

FDA Opponents Claim Abuses; Agency Doesn’t Attend Hearing

July 28, 1995